SPDR S&P Biotech ETF $XBI Holdings Decreased by Rehmann Capital Advisory Group

Rehmann Capital Advisory Group decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,146 shares of the exchange traded fund’s stock after selling 145 shares during the quarter. Rehmann Capital Advisory Group’s holdings in SPDR S&P Biotech ETF were worth $427,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of XBI. Prime Capital Investment Advisors LLC grew its stake in SPDR S&P Biotech ETF by 37.9% in the second quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock valued at $824,000 after purchasing an additional 2,729 shares in the last quarter. Cerity Partners LLC grew its stake in SPDR S&P Biotech ETF by 5.8% in the first quarter. Cerity Partners LLC now owns 18,605 shares of the exchange traded fund’s stock valued at $1,509,000 after purchasing an additional 1,016 shares in the last quarter. Farther Finance Advisors LLC grew its stake in SPDR S&P Biotech ETF by 574.5% in the second quarter. Farther Finance Advisors LLC now owns 7,082 shares of the exchange traded fund’s stock valued at $587,000 after purchasing an additional 6,032 shares in the last quarter. N.E.W. Advisory Services LLC purchased a new position in SPDR S&P Biotech ETF in the first quarter valued at about $95,000. Finally, Investment Partners Asset Management Inc. grew its stake in SPDR S&P Biotech ETF by 4.0% in the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after purchasing an additional 125 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $107.56 on Friday. The business’s 50-day moving average price is $97.73 and its two-hundred day moving average price is $87.49. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $110.96. The company has a market capitalization of $6.92 billion, a P/E ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.